Get the (PARS) Report Here
Trade with Jim Cramer 14 Days FREE
Pharmos skyrockets on positive results for its cannabinor pain treatment.
Whittier Energy shines.
Dexanabinol scores high on only one of six tests measuring cognitive function, but the next study remains key.
A drug synthesized from cannabinoid compounds targets brain traumas.
ViroPharma up after Schering-Plough licenses a cold drug.
The market has been grim, but a bounce should be imminent. Plus, charts of Apple, the S&P 500 and more.
Gary suggests a more refined way of using TA in trading. Also, charts on Juniper, the Nazz, and others.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.
©1996-2018 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.